Heterogeneity of chronic lung allograft dysfunction: Insights from protein expression in broncho alveolar lavage

Journal of Heart and Lung Transplantation

Volumn 30, Issue 6, 2011, Pages 667-673

  Verleden, Stijn E ^a   Vos, Robin ^a   Mertens, Veerle ^a   Willems Widyastuti, Anna ^a   De Vleeschauwer, Stphanie I ^a   Dupont, Lieven J ^a   Verleden, Geert M ^a   Van Raemdonck, Dirk E ^a   Vanaudenaerde, Bart M ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Pediatric Transplant Unit   (Belgium)

Author keywords

bronchiolitis obliterans syndrome; bronchoalveolar lavage; chronic lung allograft dysfunction; lung rejection; lung transplantation; neutrophilic reversible allograft dysfunction

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AZITHROMYCIN; BASIC FIBROBLAST GROWTH FACTOR; BILE ACID; FIBRONECTIN; GELATINASE B; GROWTH REGULATED ONCOPROTEIN ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; ONCOPROTEIN; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; RANTES; SCATTER FACTOR; SURFACTANT PROTEIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CELL COUNT; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROTIC BRONCHIOLITIS OBLITERANS SYNDROME; FORCED EXPIRATORY VOLUME; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MALE; NEUTROPHIL; NEUTROPHILIC REVERSIBLE ALLOGRAFT DYSFUNCTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; UPREGULATION;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BILE ACIDS AND SALTS; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LUNG TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEROXIDASE; PHENOTYPE; PRIMARY GRAFT DYSFUNCTION; PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79955877424     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.12.008     Document Type: Article

References (20)

1. M. Estenne, J.R. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 297 310 (Pubitemid 34224094)
2. J.D. Christie, L.B. Edwards, and P. Aurora The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report2009 J Heart Lung Transplant 28 2009 1031 1049
3. J. Gottlieb, J. Szangolies, T. Koehnlein, H. Golpon, A. Simon, and T. Welte Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation Transplantation 85 2008 36 41
4. B.M. Vanaudenaerde, I. Meyts, and R. Vos A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Eur Respir J 32 2008 832 843
5. G.M. Verleden, B.M. Vanaudenaerde, L.J. Dupont, and D.E. Van Raemdonck Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome Am J Respir Crit Care Med 174 2006 566 570 (Pubitemid 44330550)
6. A.R. Glanville Bronchoscopic monitoring after lung transplantation Semin Respir Crit Care Med 31 2010 208 221
7. R. Vos, B.M. Vanaudenaerde, and S.E. Verleden A randomized placebo-controlled trial of azithromycin to prevent bronchiolitis obliterans syndrome after lung transplantation Eur Respir J 2010 Jun 18
8. Standardization of spirometry1987 update Official statement of American Thoracic Society Respir Care 32 1987 1039 1060
9. K. Blondeau, V. Mertens, and B.A. Vanaudenaerde Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients J Heart Lung Transplant 28 2009 141 148
10. C. Neurohr, P. Huppmann, and B. Samweber Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients J Heart Lung Transplant 28 2009 468 474
11. M. Reynaud-Gaubert, V. Marin, and X. Thirion Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration J Heart Lung Transplant 21 2002 721 730 (Pubitemid 34718177)
12. R. Vos, B.M. Vanaudenaerde, and A. Ottevaere Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant 29 2010 1358 1368
13. G.C. Riise, P. Ericson, S. Bozinovski, S. Yoshihara, G.P. Anderson, and A. Linden Increased net gelatinase but not serine protease activity in bronchiolitis obliterans syndrome J Heart Lung Transplant 29 2010 800 807
14. S.E. Verleden, G.M. Verleden, and B.M. Vanaudenaerde Phenotyping BOS could improve understanding of mechanisms involved J Heart Lung Transplant 30 2011 112
15. G.C. Riise, and A. Linden Reply to the Letter from SE Verleden et al J Heart Lung Transplant 30 1 2011 113
16. F. D'Ovidio, M. Mura, and M. Tsang Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation J Thorac Cardiovasc Surg 129 2005 1144 1152 (Pubitemid 40631438)
17. F. D'Ovidio, M. Mura, and R. Ridsdale The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D Am J Transplant 6 2006 1930 1938 (Pubitemid 44024966)
18. X. Su, M.R. Looney, N. Gupta, and M.A. Matthay Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury Am J Physiol Lung Cell Mol Physiol 297 2009 L1 L5
19. D.I. Sternberg, R. Gowda, and D. Mehra Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice J Thorac Cardiovasc Surg 136 2008 1576 1585
20. M.A. Queisser, F.M. Kouri, and M. Konigshoff Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types Am J Respir Cell Mol Biol 39 2008 337 345